• PA
    PA School SurvivalDidactic Year
Study
  • Dashboard
  • Medical Terminology
  • Flashcards
  • Progress
  • Prep Rounds
  • Body Systems
  • Pharmacology
  • Tools
  • Guide & FAQ
  • Suggest a FeatureLet us know what we can do better — we genuinely want to help you in class.
My material
  • My Library
  • Notes & Sketches
PANCE Body Systems
  • Cardiovascular
    11%
  • Pulmonary
    9%
  • Gastrointestinal/Nutrition
    8%
  • Musculoskeletal
    8%
  • Neurology
    7%
  • Infectious Disease
    7%
  • Psychiatry/Behavioral
    7%
  • Reproductive
    7%
  • Endocrine
    6%
  • Eyes/Ears/Nose/Throat
    6%
  • Hematology
    5%
  • Renal
    5%
  • Genitourinary
    4%
  • Dermatology
    4%
Weights are study aids — verify each exam cycle.
⌘K
NotesPricingSign in
About·Tools·Terminology·Privacy Policy·Terms of Service·PANCE Blueprint

PANCE® is a registered trademark of the National Commission on Certification of Physician Assistants (NCCPA). This application is an independent study resource and is not affiliated with, sponsored by, or endorsed by the NCCPA.

For educational use only. Content is AI-generated, may contain errors, and is not medical advice — always verify against current primary sources and faculty guidance before clinical use.

HomePharmacologyCarvedilol

Carvedilol

Nonselective β-/α₁-Blocker
Drug Class
Nonselective β-/α₁-Blocker
Mechanism of Action (MOA)
Blocks β1, β2, and α1 receptors → ↓ heart rate/contractility plus vasodilation.
Black Box Warning
Ischemic heart disease — do NOT stop abruptly: abrupt cessation can cause severe exacerbation of angina, MI, and ventricular arrhythmias. Taper over 1–2 weeks.
Clinical Notes
One of three β-blockers with HFrEF mortality benefit (with metoprolol succinate, bisoprolol). Take with food to slow absorption and reduce orthostasis.
Source
FDA label
All pharmacology